Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles

[1]  Kwangmeyung Kim,et al.  Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Lei Zhang,et al.  Softer zwitterionic nanogels for longer circulation and lower splenic accumulation. , 2012, ACS nano.

[3]  G. Tiram,et al.  Administration, distribution, metabolism and elimination of polymer therapeutics. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  S. Rayala,et al.  Nanomedicine: towards development of patient-friendly drug-delivery systems for oncological applications , 2012, International journal of nanomedicine.

[5]  S. Parveen,et al.  Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[6]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[7]  Kwangmeyung Kim,et al.  Multifunctional Chitosan Nanoparticles for Tumor Imaging and Therapy , 2011 .

[8]  Jesse V Jokerst,et al.  Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.

[9]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[11]  Beom Suk Lee,et al.  Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[12]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[13]  Taro Kimura,et al.  A poly(γ-glutamic acid)–amphiphile complex as a novel nanovehicle for drug delivery system , 2010, Journal of drug targeting.

[14]  Qian Yang,et al.  Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. , 2010, Biomaterials.

[15]  Jeong Won Lee,et al.  Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles , 2010, Clinical Cancer Research.

[16]  Kwangmeyung Kim,et al.  Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Nicholas A Peppas,et al.  Targeted Nanodelivery of Drugs and Diagnostics. , 2010, Nano today.

[18]  Ming-Jium Shieh,et al.  Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. , 2010, Bioconjugate chemistry.

[19]  Ick Chan Kwon,et al.  Targeted delivery of low molecular drugs using chitosan and its derivatives. , 2010, Advanced drug delivery reviews.

[20]  Ick Chan Kwon,et al.  Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy. , 2010, Bioconjugate chemistry.

[21]  Ick Chan Kwon,et al.  Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[22]  W. Choe,et al.  Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Liangfang Zhang,et al.  Therapeutic nanoparticles to combat cancer drug resistance. , 2009, Current drug metabolism.

[24]  Joseph M DeSimone,et al.  Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[25]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[26]  Sen-ming Wang,et al.  [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier]. , 2008, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[27]  Byung-Heon Lee,et al.  Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis , 2008, Journal of cellular and molecular medicine.

[28]  T. Minko,et al.  Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[29]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[30]  Y. Byun,et al.  Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth. , 2008, Bioconjugate chemistry.

[31]  Ick Chan Kwon,et al.  A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[32]  I. Kwon,et al.  Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[34]  K. Ulbrich,et al.  New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Jing Zhao,et al.  Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel , 2008, Nanotechnology.

[36]  Kwangmeyung Kim,et al.  Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[37]  B. Kelly,et al.  The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimers. , 2008, Molecular pharmaceutics.

[38]  E. Kang,et al.  Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. , 2008, Biomaterials.

[39]  Mark E. Davis,et al.  Impact of tumor‐specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA‐containing nanoparticles , 2008, Biotechnology and bioengineering.

[40]  Ick Chan Kwon,et al.  Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[41]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[42]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[43]  Gert Storm,et al.  Sheddable Coatings for Long-Circulating Nanoparticles , 2007, Pharmaceutical Research.

[44]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[45]  Mansoor M. Amiji,et al.  Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery , 2007, Pharmaceutical Research.

[46]  J. Panda,et al.  The present and future of nanotechnology in human health care. , 2007, Nanomedicine : nanotechnology, biology, and medicine.

[47]  Daniel S Kohane,et al.  Microparticles and nanoparticles for drug delivery. , 2007, Biotechnology and bioengineering.

[48]  H. Maeda,et al.  Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.

[49]  M. Rinaudo,et al.  Chitin and chitosan: Properties and applications , 2006 .

[50]  U. Nielsen,et al.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.

[51]  Robert Langer,et al.  Nanoparticle–aptamer bioconjugates for cancer targeting , 2006, Expert opinion on drug delivery.

[52]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Junginger,et al.  Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[54]  Ick Chan Kwon,et al.  Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[55]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[56]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[57]  Kwangmeyung Kim,et al.  Physicochemical characterizations of self-assembled nanoparticles of glycol chitosan-deoxycholic acid conjugates. , 2005, Biomacromolecules.

[58]  J. Mano,et al.  Chitosan-Based Particles as Controlled Drug Delivery Systems , 2004, Drug delivery.

[59]  Ick Chan Kwon,et al.  Physicochemical Characteristics of Self-Assembled Nanoparticles Based on Glycol Chitosan Bearing 5β-Cholanic Acid , 2003 .

[60]  I. Kwon,et al.  Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[61]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[62]  R. Puri,et al.  Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[63]  R. Puri,et al.  Interleukin 4 Receptor on Human Lung Cancer , 2002 .

[64]  Alexander V Kabanov,et al.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. , 2002, Advanced drug delivery reviews.

[65]  A. Maitra,et al.  Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[66]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[67]  Y Wang,et al.  Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[68]  Hiroshi Maeda,et al.  Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues , 1998, Japanese journal of cancer research : Gann.

[69]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[70]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[71]  H. Rennke,et al.  The Structural and Molecular Basis of Glomerular Filtration , 1978, Circulation research.

[72]  Robert Blumenthal,et al.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. , 2009, Critical reviews in therapeutic drug carrier systems.

[73]  J. Dutta,et al.  Chitin and chitosan: Chemistry, properties and applications , 2004 .

[74]  J. Fernandes,et al.  Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  H. Junginger,et al.  Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. , 2002, Biomaterials.